Extended Follow-Up Reaffirms Benefit of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma

Press/Media

Period	7 Mar 2023

Media coverage

Title	Extended Follow-Up Reaffirms Benefit of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
Media name/outlet	OncLive
Country/Territory	United States
Date	7/03/23
URL	ct.moreover.com/?a=50188225162&p=1gw&v=1&x=hNRA7KU524ErCA2RxSlVVA
Persons	Matthew Galsky